Log in Book a Demo

US Pharma & Biotech Pulmonology - PPC Market Share Analysis July 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Pulmonology category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Pulmonology – US

Google AI Overview visibility for Pharma & Biotech Pulmonology US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 72.1554290883
27.8445709117
72%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 14
86
14%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 2%
Transactional 7%
Navigational 0%
Seasonal 0%
Local 1%
Problem Solving 28%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Pulmonology brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data
Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
breztri.com 31.07
dupixenthcp.com 12.16
dupixent.com 9.06
breztrihcp.com 8.48
zoryvehcp.com 6.01
trelegy.com 3.55
nucala.com 3.37
zoryve.com 2.99
trelegyhcp.com 2.82
yupelrihcp.com 2.71
others 17.78
  • breztri.com - 31.07%
  • dupixenthcp.com - 12.16%
  • dupixent.com - 9.06%
  • breztrihcp.com - 8.48%
  • zoryvehcp.com - 6.01%
  • trelegy.com - 3.55%
  • nucala.com - 3.37%
  • zoryve.com - 2.99%
  • trelegyhcp.com - 2.82%
  • yupelrihcp.com - 2.71%
  • others - 17.78%

Copyright © Adthena. All rights reserved.

In the PPC landscape, breztri.com dominates with 31.07% click share, while ‘others’ collectively hold 17.78%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Pulmonology brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

See more data
Share of Spend - Last Month
Share of Spend - Last Month
Date breztri.com dupixenthcp.com trelegyhcp.com dupixent.com zoryve.com trelegy.com breztrihcp.com zoryvehcp.com nucala.com yupelrihcp.com
2026/07/01 25.41% 12.51% 0.84% 9.87% 3.51% 1.65% 11.71% 1.1% 1.72% 4.97%
2026/07/02 30.92% 14.05% 3.25% 12.47% 1.11% 2.08% 10.05% 3.07% 2.09% 2.21%
2026/07/03 24.64% 10.47% 1.25% 13% 1.17% 5.71% 13.08% 1.61% 2.72% 4.69%
2026/07/04 19.67% 11.72% 0.52% 16.35% 1.03% 5.92% 12.84% 5.2% 0.78% 3.38%
2026/07/05 21.34% 13.62% 0.59% 10.27% 0% 4.76% 15.38% 4.42% 2.86% 3.16%
2026/07/06 27.69% 18.07% 0.63% 14.33% 1.65% 3.02% 11.31% 2.27% 3.83% 1.88%
2026/07/07 25.36% 16.64% 0.49% 10.02% 0% 5.01% 8.29% 3.39% 1.24% 4.65%
2026/07/08 26.42% 15.51% 0.77% 11.88% 0% 7.19% 12.43% 3.03% 4.97% 2.31%
2026/07/09 29.39% 18.14% 2.19% 5.18% 0% 9.27% 8.72% 4.05% 4.78% 1.62%
2026/07/10 33.56% 15.14% 1.27% 6.38% 3.32% 4.46% 13.72% 3.85% 1.48% 3.35%
2026/07/11 35.9% 23.79% 1.83% 3.86% 0% 4.11% 7.57% 4.68% 0.56% 7.07%
2026/07/12 25.4% 13.48% 2.23% 6.38% 2.03% 11.8% 10.39% 9.42% 4.88% 1.99%
2026/07/13 37.58% 11.05% 1.41% 13.28% 1.73% 4.04% 10.57% 1.62% 0.42% 4.59%
2026/07/14 29.83% 14.99% 15.26% 3.71% 3.12% 2.91% 7.23% 4.29% 3.86% 3.09%
2026/07/15 36.83% 12.42% 7.31% 3.4% 10.37% 2.07% 3.41% 7.47% 0.76% 4.29%
2026/07/16 37.61% 7.21% 21.85% 2.41% 4.45% 2.07% 10.35% 0% 3.31% 0.54%
2026/07/17 45.62% 15.41% 3.79% 6.29% 8.61% 2.45% 5.31% 0% 1.37% 1.56%
2026/07/18 36.03% 13.78% 1.35% 8.43% 2.15% 1.63% 8.01% 2.02% 2.06% 2.25%
2026/07/19 35.33% 10.96% 1.97% 14.49% 3.3% 2.23% 6.42% 3.1% 0.75% 1.49%
2026/07/20 31.71% 13.23% 1.94% 11.69% 7.95% 2.42% 7.95% 5.48% 1.51% 0.4%
2026/07/21 29.83% 14.99% 15.26% 3.71% 3.12% 2.91% 7.23% 4.29% 3.86% 3.09%
2026/07/22 44.47% 15.26% 1.61% 9.51% 0% 4.38% 7.71% 3.46% 2.37% 2.49%
2026/07/23 38.11% 15.92% 2.16% 5.75% 2.9% 2.69% 8.47% 7.36% 2.06% 3.71%
2026/07/24 37.73% 18% 1.45% 11.15% 0% 6.5% 6.32% 1.77% 4.16% 2.45%
2026/07/25 39.69% 10% 2.87% 7.7% 3.67% 5.25% 4.76% 6.15% 4.91% 1.79%
2026/07/26 43.58% 9.99% 2.13% 10.84% 0.96% 2.5% 7.91% 2.71% 3.99% 1.12%
2026/07/27 33.46% 15.69% 1.04% 11.34% 1.8% 6.19% 8.29% 6.24% 3.18% 2.07%
2026/07/28 37.33% 13.76% 1.84% 10.31% 0.99% 8.9% 6.69% 5.03% 2.56% 1.02%
2026/07/29 27.32% 18.93% 3.18% 10.49% 1.3% 5.29% 8.54% 6.01% 1.38% 3.78%
2026/07/30 43.39% 11.26% 1.92% 7.07% 1.44% 6.04% 9.19% 1.36% 3.09% 3.28%
2026/07/31 29.43% 16.95% 9.4% 7% 6.27% 4.83% 4.71% 2.16% 1.75% 1.06%
  • breztri.com
  • dupixenthcp.com
  • trelegyhcp.com
  • dupixent.com
  • zoryve.com
  • trelegy.com
  • breztrihcp.com
  • zoryvehcp.com
  • nucala.com
  • yupelrihcp.com

Copyright © Adthena. All rights reserved.

Breztri.com led July with fluctuating dominance, peaking mid-month. Dupixenthcp.com showed steady growth, while Trelegyhcp.com surged late. Dupixent.com and Zoryve.com had varied performances. Breztrihcp.com and Zoryvehcp.com maintained moderate shares. Nucala.com and Yupelrihcp.com had sporadic spikes.

Market Exposure

Competitor Count for US Pharma & Biotech Pulmonology

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

See more data
Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/07/01 29
2026/07/02 24
2026/07/03 25
2026/07/04 28
2026/07/05 27
2026/07/06 26
2026/07/07 29
2026/07/08 29
2026/07/09 26
2026/07/10 26
2026/07/11 23
2026/07/12 25
2026/07/13 26
2026/07/14 28
2026/07/15 29
2026/07/16 25
2026/07/17 26
2026/07/18 26
2026/07/19 27
2026/07/20 24
2026/07/21 28
2026/07/22 26
2026/07/23 26
2026/07/24 29
2026/07/25 27
2026/07/26 28
2026/07/27 28
2026/07/28 27
2026/07/29 26
2026/07/30 26
2026/07/31 28

Copyright © Adthena. All rights reserved.

July saw fluctuating advertiser numbers, peaking at 29 and dipping to 23. The month concluded with a stable 28 advertisers.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Pulmonology

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data
Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
breztri.com 7.29%
goodrx.com 2.03%
zoryvehcp.com 0.7%
dupixent.com 0.42%
zoryve.com 0.35%
yupelrihcp.com -0.79%
dupixenthcp.com -0.84%
mayoclinic.org -1.4%
yupelri.com -1.8%
breztrihcp.com -3.19%

Copyright © Adthena. All rights reserved.

Breztri.com surged with a 7.29% click share increase, while breztrihcp.com dropped by 3.19%. Goodrx.com rose by 2.03%, contrasting with yupelri.com’s 1.8% decline.

Campaign Efficiency

US Pharma & Biotech Pulmonology Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data
Date breztri.com zoryve.com dupixenthcp.com trelegyhcp.com dupixent.com breztrihcp.com zoryvehcp.com trelegy.com nucala.com yupelrihcp.com
2026/07/01 20.83% 9.22% 9.89% 0.52% 10.99% 9.87% 3.07% 0.88% 2.66% 5.99%
2026/07/02 25.53% 3.04% 12.1% 3.45% 13.43% 9.17% 6.09% 1.13% 4.42% 2.13%
2026/07/03 22.5% 3.75% 9.23% 2.03% 13.05% 13.71% 3.75% 3.88% 2.31% 5.24%
2026/07/04 17.85% 2.74% 10.47% 0.34% 14.75% 12.44% 10.96% 3.5% 0.75% 3.96%
2026/07/05 19.86% 0% 12.65% 0.41% 10.87% 16.51% 9.3% 2.87% 2.1% 3.36%
2026/07/06 21.5% 4.53% 18.39% 0.42% 15.79% 9.72% 4.53% 1.55% 6.35% 2.04%
2026/07/07 22.7% 0% 14.18% 0.31% 10.35% 8.37% 6.69% 3.63% 2.01% 4.76%
2026/07/08 22.87% 0% 12.78% 0.5% 11.9% 13.71% 5.42% 4.34% 8.06% 4.5%
2026/07/09 22.95% 0% 14.6% 1.9% 5.15% 8.45% 7.62% 5.98% 11.69% 1.69%
2026/07/10 28.68% 9.16% 11.85% 0.82% 5.75% 15.52% 9.16% 1.94% 1.09% 3.39%
2026/07/11 27.96% 0% 21.86% 1.3% 3.05% 8.73% 15.07% 2.51% 0.8% 9.28%
2026/07/12 18.92% 5.77% 12.01% 1.52% 4.91% 11.16% 23.08% 8.16% 3.68% 2%
2026/07/13 36.74% 4.48% 8.41% 0.86% 11.83% 10.31% 4.48% 6.32% 0.52% 4.18%
2026/07/14 22.15% 8.54% 15.08% 14.4% 3.59% 7.24% 8.54% 1.43% 9.18% 2.58%
2026/07/15 30.17% 22.77% 9.53% 4.66% 1.81% 2.3% 13.66% 1.05% 0.65% 3.58%
2026/07/16 33.06% 13.05% 4.78% 22.03% 1.95% 11.62% 0% 1.32% 4.63% 0.55%
2026/07/17 36.9% 24.06% 12.89% 3.99% 7.2% 4.48% 0% 1.46% 1.43% 1.53%
2026/07/18 36.18% 6.63% 11.52% 1.02% 7.21% 7.78% 6.63% 1.11% 1.71% 1.9%
2026/07/19 28.79% 8.87% 7.53% 1.3% 11.28% 5.14% 8.87% 1.3% 9.5% 1.43%
2026/07/20 20.12% 21.4% 12.17% 1.31% 9.5% 8.03% 10.7% 1.45% 1.54% 0.39%
2026/07/21 22.15% 8.54% 15.08% 14.4% 3.59% 7.24% 8.54% 1.43% 9.18% 2.58%
2026/07/22 37.48% 0% 13.85% 1.31% 9.05% 9.62% 12.48% 2.61% 4.3% 2.97%
2026/07/23 33.42% 7.94% 12.59% 1.47% 4.15% 8.43% 15.88% 1.28% 2% 2.9%
2026/07/24 24.7% 0% 11.76% 0.73% 18.92% 3.36% 2.62% 2.74% 15.17% 1.34%
2026/07/25 34.85% 8.6% 7.63% 2.33% 7.08% 3.93% 14.33% 3.07% 4.08% 1.46%
2026/07/26 34.61% 2.6% 9.33% 1.69% 9.63% 7.93% 7.81% 1.2% 9.41% 1.06%
2026/07/27 27.87% 4.78% 13.16% 0.73% 11.94% 8.12% 14.35% 4.75% 2.84% 1.38%
2026/07/28 33.55% 2.88% 12.9% 1.3% 10.82% 7.18% 11.52% 5.23% 2.47% 1%
2026/07/29 21.08% 3.82% 16.26% 3.44% 10.42% 8.47% 15.28% 3.92% 2.23% 3.02%
2026/07/30 41.91% 4.46% 10.2% 1.64% 7.78% 11.8% 4.46% 3.89% 2.23% 3.64%
2026/07/31 21.28% 17.85% 17.18% 8.92% 8.66% 5.2% 4.46% 3.17% 2.83% 1.01%
  • breztri.com
  • zoryve.com
  • dupixenthcp.com
  • trelegyhcp.com
  • dupixent.com
  • breztrihcp.com
  • zoryvehcp.com
  • trelegy.com
  • nucala.com
  • yupelrihcp.com

Copyright © Adthena. All rights reserved.

Breztri.com led July with fluctuating impressions, peaking at 41.91% on the 30th. Zoryve.com saw a notable rise on the 31st, reaching 17.85%. Dupixenthcp.com maintained steady visibility, while Trelegyhcp.com spiked mid-month. The month concluded with Breztri.com dominating.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pulmonology

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data
Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Pulmonology - Last month
  1. 1
    3 Medicines In 1 COPD Inhaler - May Improve Lung Function

    Learn How This COPD Inhaler Option May Help To Reduce Your COPD Flare-Ups.

  2. 2
    FDA-Approved Treatment Option - Official HCP Website https://www.breztrihcp.com/

    BREZTRI AEROSPHERE® (budesonide/glycopyrrolate/formoterol fumarate) - Now Approved.

  3. 3
    Add-On Treatment For COPD - The Official Patient Site Prescription treatment website

    COPD With An Eosinophilic Phenotype Treatment Administered At Home. See Dosing Information

  4. 4
    ZORYVE® (roflumilast) - A Once-Daily Treatment Option https://www.zoryve.com/

    Discover ZORYVE, a once-daily treatment. Find out if it suits your treatment journey. See how this once-daily treatment option can fit into your daily routine. Common side effects. Patient brochure.

  5. 5
    ZORYVE® (roflumilast) - For Healthcare Professionals https://www.zoryvehcp.com/formulation

    Review the formulation information. See if it may be right for your patients. View information and resources intended for healthcare professionals.

Copyright © Adthena. All rights reserved.

In the competitive landscape of COPD treatments, Breztri and Zoryve stand out with compelling narratives. Breztri’s ads emphasize a triple-action inhaler promising improved lung function and reduced flare-ups, while Zoryve highlights a convenient once-daily treatment, appealing to both patients and healthcare professionals.

Frequently Asked Questions

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.